Acute Otitis Externa: Efficacy and Tolerability of N-Chlorotaurine, a Novel Endogenous Antiseptic Agent

Laryngoscope

Volumn 114, Issue 5, 2004, Pages 850-854

  Neher, Andreas ^a   Nagl, Markus ^b   Appenroth, Elisabeth ^a   Gstöttner, Michaela ^a   Wischatta, Martin ^a   Reisigl, Franz ^a   Schindler, Martin ^a   Ulmer, Hanno ^b   Stephan, Kurt ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

N chlorotaurine; Otitis externa; Otosporin; Swimmers ear

Indexed keywords

ANTIINFECTIVE AGENT; CORTISPORIN; N CHLOROTAURINE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AQUEOUS SOLUTION; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; EXTERNAL OTITIS; FEMALE; HUMAN; INFLAMMATION; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE BLIND PROCEDURE; STAPHYLOCOCCUS AUREUS; SWIMMING; TREATMENT FAILURE; VISUAL ANALOG SCALE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CHILD; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEOMYCIN; OTITIS MEDIA; POLYMYXIN B; TAURINE;

EID: 2442444321     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200405000-00011     Document Type: Article

References (26)

1. Sander R. Otitis externa: a practical guide to treatment and prevention. Am Fam Physician 2001;63:927-922.
2. Bojrab DI, Bruderly T, Abdulrazzak Y. Otitis externa. Otolaryngol Clin North Am 1996;29:761-782.
3. Kristiansen P. The diagnosis and management of malignant (necrotizing) otitis externa. J Am Acad Nurse Pract 1999; 11:297-300.
4. Jinn TH, Kim PD, Russell PT, et al. Determination of ototoxicity of common otic drops using isolated cochlear outer hair cells. Laryngoscope 2001;111:2105-2108.
5. Nagl M, Pfausler B, Schmutzhard E, et al. Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zentralbl Bakteriol 1998;288:217-223.
6. Nagl M, Miller B, Daxecker F, et al. Tolerance of N-chlorotaurine, an endogenous antimicrobial agent, in the rabbit and human eye: a phase I clinical study. J Ocul Pharmacol Ther 1998;14:283-290.
7. Nagl M, Teuchner B, Pöttinger E, et al. Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis: a phase H pilot study. Ophthalmologica 2000;214:111-114.
8. Nagl M, Nguyen VA, Gottardi W, et al. Tolerability and efficacy of N-chlorotaurine compared to chloramine T for treatment of chronic leg ulcers with purulent coating. Br J Dermatol 2003;149:590-597.
9. Neher A, Nagl M, Schrott-Fischer A, et al. N-chlorotaurine, a novel endogenous antimicrobial agent: tolerability tested in a mouse model. Arch Otolaryngol Head Neck Surg 2001; 127:530-533.
10. Stelmaszynska T, Zgliczynski JM. Myeloperoxidase of human neutrophilic granulocytes as chlorinating enzyme. Eur J Biochem 1974;45:305-312.
11. Harrison JE, Schultz J. Studies on the chlorinating activity of myeloperoxidase. J Biol Chem 1976;251:1371-1374.
12. Thomas EL. Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: effect of exogenous amines on the antibacterial action against Escherichia coli. Infect Immun 1979;25:110-116.
13. Weiss SJ, Lampert MB, Test ST. Long-lived oxidants generated by human neutrophils: characterization and bioactivity. Science 1983;222:625-628.
14. Nagl M, Gottardi W. Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds. Hyg Med 1996;21:597-605.
15. Nagl M, Hengster P, Semenitz E, Gottardi W. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J Antimicrob Chemother 1999;43:805-809.
16. Nagl M, Hess M, Pfaller K, et al. Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defence system. Antimicrob Agents Chemother 2000;44:2507-2513.
17. Nagl M, Lass-Floerl C, Neher A, et al. Enhanced fungicidal activity of N-chlorotaurine in nasal secretion. J Antimicrob Chemother 2001;47:871-874.
18. Gottardi W, Nagl M. Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm (Weinheim) 2002;335:411-421.
19. Bilzer M, Lauterburg BH. Effects of hypochlorous acid and chloramines on vascular resistance, cell integrity, and biliary glutathione disulfide in the perfused rat liver: modulation by glutathione. J Hepatol 1991;13:84-89.
20. Kontny E, Grabowska A, Kowalczewski J, et al. Taurine chloramine inhibition of cell proliferation and cytokine production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum 1999;42:2552-2560.
21. Marcinkiewicz J, Nowak B, Grabowska A, et al. Regulation of murine dendritic cell functions in vitro by taurine chloramine, a major product of the neutrophil myeloperozidase-halide system. Immunology 1999;98:371-378.
22. Park E, Levis WR, Quinn MR, et al. Regulation of nitric oxide induced by mycobacterial lipoarabinomannan in murine macrophages: effects of interferon-beta and taurine-chloramine. Int J Lepr Other Mycobact Dis 2000;68: 444-451.
23. Nagl M, Gruber A, Fuchs A, et al. Impact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp. Antimicrob Agents Chemother 2002;46: 1996-1999.
24. Marcinkiewicz J. Neutrophil chloramines: missing links between innate and acquired immunity. Immunol Today 1997;18:577-580.
25. Barua M, Liu Y, Quinn MR. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity. J Immunol 2001;167:2275-2281.
26. Park E, Jia J, Quinn MR, Schuller-Levis G. Taurine chloramine inhibits lymphocyte proliferation and decreases cytokine production in activated human leukocytes. Clin Immunol 2002;102:179-184.